enGene Therapeutics Inc

ENGNNASDAQ · USD
1.80USD-0.09 (-4.77%)
529

enGene Therapeutics Inc (ENGN) Option Chain

Read more

Tracking the ENGN option chain helps you see every strike and expiry on enGene Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ENGN options activity at a glance. Use our scanner to monitor the ENGN option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ENGN stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ENGN options are being actively traded, and where they are not.

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.003,867480.400.80—1.201.00-47.09—0.050.000.050200100.00
70.9914130.780.000.051.502.00+5.820.050.200.20-0.07145029.01
100.005310.050.00—0.053.00+58.730.351.501.20-0.27000.00

As of Nov 16, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank—
  • Market cap (M$)127
  • 52 weeks high-84.57%
  • 52 weeks low35.00%
  • Analyst recommendationBuy
    1.70
  • Target price$4.38
    94.44% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-12-22
  • P/E—
  • Future P/E—
  • EPS (ttm)-2.08
  • EPS growth next 5 years20.71%

As of Nov 16, 2026